Skip to main content

Table 3 Associations of trajectory clusters for individual CVD risk factors (representing low, medium and high cumulative exposure to this risk factor over 14 years) with CMR derived measures of cardiac structure and function

From: Association of antecedent cardiovascular risk factor levels and trajectories with cardiovascular magnetic resonance-derived cardiac function and structure

CV risk factor clustersa

N

Left ventricle

Right ventricle

Cardiac fat

End-diastolic volumeb

Stroke volumeb

Myocardial mass, diastolicb

Early diastolic filling rate

End-diastolic volumeb

Stroke volumeb

Epicardial fat, diastolic

Pericardial fat, diastolic

349

β (95% CI)

β (95% CI)

β (95% CI)

β (95% CI)

β (95% CI)

β (95% CI)

β (95% CI)

β (95% CI)

Systolic BP (low)

101

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

 (middle)

149

0.03 (− 4.13; 4.19)

1.00 (− 1.58; 3.57)

2.13 (− 1.32; 5.58)

− 18.47 (− 48.99; 12.04)

− 0.26 (− 4.9; 4.37)

0.97 (− 1.56; 3.5)

− 0.40 (− 1.44; 0.65)

− 2.68 (− 6.10; 0.75)

 (high)

99

3.23 (− 2.48; 8.93)

2.46(− 1.07; 6.00)

7.42** (2.69; 12.16)

− 31.73 (− 73.58; 10.13)

1.73 (− 4.72; 8.19)

2.12 (− 1.40; 5.64)

0.02 (− 1.41; 1.45)

0.09 (− 4.58; 4.76)

Diastolic BP (low)

135

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

 (middle)

142

− 2.76 (− 6.83; 1.3)

− 1.42 (− 3.93; 1.08)

− 1.29 (− 4.64; 2.05)

− 24.42 (− 54.13; 5.29)

− 2.01 (− 6.55; 2.52)

− 1.06 (− 3.53; 1.40)

0.11 (− 0.90; 1.11)

− 0.80 (− 4.13; 2.52)

 (high)

72

− 4.63 (− 10.32; 1.06)

− 4.61* (− 8.12; − 1.10)

− 2.53 (− 7.21; 2.16)

− 54.49* (− 96.09; − 12.89)

− 5.77 (− 12.05; 0.51)

− 4.31* (− 7.72; − 0.90)

2.12** (0.71; 3.52)

5.02* (0.39; 9.65)

Waist circumference (low)

97

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

 (middle)

180

− 4.31* (− 8.53; − 0.09)

− 3.18* (− 5.79; − 0.56)

2.23 (− 1.18; 5.65)

− 10.68 (− 41.49; 20.12)

− 6.59** (− 11.39; − 1.79)

− 3.05* (− 5.66; − 0.43)

2.21*** (1.11; 3.31)

6.42** (2.68; 10.16)

 (high)

72

− 8.9** (− 14.36; − 3.45)

− 5.47** (− 8.86; − 2.09)

1.90 (− 2.51; 6.31)

− 22.5(− 62.3; 17.29)

− 10.62** (− 16.81; − 4.44)

− 4.54** (− 7.9; − 1.18)

4.29*** (2.89; 5.70)

15.31*** (10.52; 20.11)

HbA1c (low)

159

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

 (middle)

169

− 1.23 (− 4.53; 2.08)

− 1.26 (− 3.30; 0.79)

0.35 (− 2.40; 3.09)

− 0.21 (− 24.52; 24.11)

− 0.25 (− 3.91; 3.41)

− 0.49 (− 2.49; 1.51)

− 0.45 (− 1.28; 0.39)

− 0.99 (− 3.75; 1.76)

 (high)

21

6.24 (− 4.98; 17.47)

1.31 (− 5.65; 8.26)

7.92 (− 1.41; 17.25)

58.2 (− 24.41; 140.82)

7.05 (− 5.68; 19.78)

2.22 (− 4.73; 9.17)

− 3.28* (− 6.13; − 0.42)

− 8.44 (− 17.86; 0.97)

LDL-C (low)

103

Ref

Ref

Ref

Ref

Ref

Ref

Ref

Ref

 (middle)

149

− 1.41 (− 5.06; 2.24)

− 1.19 (− 3.43; 1.05)

− 1.91 (− 4.91; 1.1)

− 1.60 (− 28.45; 25.26)

1.15 (− 2.88; 5.18)

0.19 (− 2.00; 2.38)

− 0.38 (− 1.32; 0.55)

− 0.19 (− 3.28; 2.89)

 (high)

97

− 6.75** (− 10.96; − 2.54)

− 5.16*** (− 7.74; − 2.58)

− 2.77 (− 6.23; 0.69)

− 33.48* (− 64.41; − 2.55)

− 6.14* (− 10.82; − 1.46)

− 3.54* (− 6.09; − 1.00)

0.05 (− 1.01; 1.12)

1.22 (− 2.29; 4.73)

  1. Data are β coefficients (with 95% confidence interval; indicating change in outcome variable between reference cluster and risk factor cluster) from multivariable linear regression models adjusted for the other risk factors respectively and for age, sex, smoking status, alcohol consumption, physical activity, antihypertensive medication, lipid-lowering medication, glucose-lowering medication measured in Exam 3
  2. Ref. reference cluster
  3. ***p < 0.001; **p < 0.01; *p < 0.05
  4. aClusters were calculated by k-means clustering
  5. bIndexed to body surface area